Erythema Nodosum Leprosum
📧 Sign up to get email alerts when something new happens for Erythema Nodosum Leprosum.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of dovramilast in people with erythema nodosum leprosum (leprosy type 2 reaction…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum [NA]
Update on a methotrexate and prednisolone trial for erythema nodosum leprosum, noting the study status as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum [Phase 4]
Phase 4 trial evaluating efficacy and safety of Apremilast in patients with Erythema Nodosum Leprosum has been completed.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum [Phase 2]
Clinical trial update for CC-11050 in Nepalese patients with Erythema Nodosum Leprosum (ENL) in Phase 2.
-
FDA approval · 2019-12-04FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for Thalomid (thalidomide) submitted by Celgene Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-11-30FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum [Phase 2]
A Phase 2 clinical trial evaluating ciclosporin for the management of chronic or recurrent erythema nodosum leprosum in leprosy has complete…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Ciclosporin in the Management of New Erythema Nodosum Leprosum [Phase 2]
A Phase 2 clinical trial evaluating ciclosporin for the management of new erythema nodosum leprosum in patients with leprosy; the study stat…
-
FDA approval · 2014-09-12FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation, resulting in an expanded indication.
-
CLINICAL_TRIALS research · 2006-12-04Clinical Trial Update: Montelukast in ENL Reaction [NA]
Clinical trial update on montelukast for erythema nodosum leprosum and leprosy with unknown trial status.